跳至主要内容
临床试验/CTRI/2023/04/051906
CTRI/2023/04/051906尚未招募不适用

Primary Objective:To assess the efficacy of two skin care formulations, post routine sun exposure in terms of moisturization, skin radiance, skin brightening, improvement in even skin tone on healthy female subjects.Secondary Objective:To assess the efficacy of two skin care formulations, post routine sun exposure in terms of skin firmness, reduction in dark spots (acne PIH), reduction in under eye dark circles, skin oiliness/sebum on healthy female subjects.

EMAMI LTD.1 个研究点 分布在 1 个国家目标入组 72 人开始时间: 2023年4月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
72
试验地点
1
主要终点
moisturization, skin radiance, skin brightening, improvement in even skin tone

研究概览

简要总结

OBJECTIVETo evaluate & comparethe in-vivo safety and efficacy of two skin care formulations post routine sunexposure in terms of moisturization, skin radiance, skin brightening,improvement in even skin tone, skin firmness, reduction in dark spots (acnePIH), reduction in under eye dark circles, skin oiliness/sebum on healthyfemale subjects

Primary Objective: To assess the efficacy oftwo skin care formulations, post routine sun exposure in terms ofmoisturization, skin radiance, skin brightening, improvement in even skin tone.

SecondaryObjective: Toassess the efficacy of two skin care formulations, post routine sun exposure interms of skin firmness, reduction in dark spots (acne PIH), reduction inunder eye dark circles, skin oiliness/ sebum.

Product :Fairness Cream1, Fairness Cream 2

The evaluation is performed using:Subject SelfEvaluation, Dermatological Evaluation: Cosmetic Acceptability, DermatologicalEvaluation: Efficacy, Chromametry, Corneometry, CLBT (Color, Luminosity,Brightness, Transparency), Sebumetery, Mexametry, Tewametry, Cutometry, ExpertEvaluation: Assessment of Transfer-Proof & Water-ProofEfficacy, Analysis of the skin color through cross polarized light ,Illustrative Images of whole face & ¾ th face under Diffused Light

Totalduration of the study: 21 days

Kinetics:Day 1 (T1)- T0, T+10 minutes(T2), T+4 hours (post sun exposure) (T3), T+8 hours (T4), T+10 hours (T5), Day7 (T6)-T+7 days, T+10 minutes (T7), T+4 hours (post sun exposure) (T8), T+8hours (T9), T+10 hours (T10), Day 14 (T11)- T+14 Days, Day 21 (T12)- T+21 Days,T+10 minutes (T13), T+4 hours (post sun exposure) (T14), T+8 hours (T15), T+10hours (T16)

Productapplication: Twice a day, morning and evening

Numberof volunteers: 72 (36 perproduct) female subjects.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 35.00 Year(s)(—)
性别
Female

入选标准

  • 1Indian female subjects 2Healthy subjects (no infectious and evolutive pathology which could make the subject vulnerable and stop the study, no pathology which could interfere with the study, no symptom in the process of an exploratory checkup) 3Between 18 and 35 years of age.
  • 4Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar) 5Having dull skin with dark spots (acne PIH) 6Having under eye dark circle 7Having dark to wheatish skin (L between 45 to 55) 8Having oily to mixed oily skin type 9Having daily routine involving atleast 2 hours sun exposure.

排除标准

  • 1Being pregnant or breastfeeding or having stopped to breastfeed in the past three months 2Having refused to give her assent by not signing the consent form 3Taking part in another study liable to interfere with this study 4Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 6Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products.
  • 7Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • 8Having cutaneous hypersensitivity.
  • 9Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • 10Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit.
  • 11Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted) 12Refusing to follow the restrictions below during the study:Do not take part in any family planning activities leading to pregnancy and breastfeeding.
  • Do not take part in another study liable to interfere with this study.
  • Do not take medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol).
  • Do not change their cosmetic habits apart from the particular conditions mentioned in the protocol, on the studied anatomic unit, During the study: Do not use other cosmetic products than the tested products to the studied areas, The day of the measurements: No test product must be used (only face cleaned with water is accepted) 13Having started, changed or interrupted one hormonal treatment (hormonal contraception, Hormone Replacement Therapy) during the past 3 months 14Having started, changed or stopped her tobacco consumption (for smokers consuming more than 10 cigarettes per day) in the previous 6 months 15Having consumed caffeine-based products (coffee, cola, tea, …), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements.
  • 16Having taken a medicinal treatment which could lead to hyper pigmentation (phenytoïn, amiodarone, metals, minocycline…) in the previous 6 months.
  • 17Taking oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…) 18Having had beauty treatment (e.g., skin cleansing, exfoliation, scrub, mask …) or having applied self-tanning products in the week preceding the start of the study 19Having applied products with anti-wrinkle action (Retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A...) in the 2 weeks preceding the start of the study 20Having applied products with a depigmenting/ whitening action (hydroquinone or derivates…) in the 4 weeks preceding the start of the study.
  • 21Having a suntanned skin on the studied areas which could interfere with the evaluations of the study 22Refusing to follow the restrictions below during the study:Do not start, change or stop a hormonal treatment (hormonal contraception, Hormone Replacement Therapy), Do not start a medicinal treatment which could lead to hyper pigmentation, Do not take oral supplements with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene…), Do not consume caffeine-based products (coffee, cola, tea, …), alcohol, highly spiced food and/or not smoke in the two hours preceding the measurements, Do not have beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask …) or apply self-tanning products, Do not use products or techniques or surgery with a depigmenting / whitening action, Do not expose herself to the sun by respecting a strict photo-protection.

结局指标

主要结局

moisturization, skin radiance, skin brightening, improvement in even skin tone

时间窗: Baseline, 10 minutes, 4 hours, 8 hours, 10 hours, 7 days (10 minutes, 4 hours, 8 hours, 10 hours), Day 14(10 minutes, 4 hours, 8 hours, 10 hours), Day 21(10 minutes, 4 hours, 8 hours, 10 hours)

次要结局

  • firmness, reduction in dark spots (acne PIH), reduction in under eye dark circles, skin oiliness/ sebum(Baseline, 10 minutes, 4 hours, 8 hours, 10 hours, 7 days (10 minutes, 4 hours, 8 hours, 10 hours), Day 14(10 minutes, 4 hours, 8 hours, 10 hours), Day 21(10 minutes, 4 hours, 8 hours, 10 hours))

研究者

发起方
EMAMI LTD.
申办方类型
Other [fmcg]

研究点 (1)

Loading locations...

相似试验